Semaglutide-Glycine-Cyanocobalamin Injectable
Northwest Compounders is recalling Semaglutide-Glycine-Cyanocobalamin Injectable vials due to lack of assurance of sterility.
Do not use this medication. Contact your pharmacy or healthcare provider immediately for a replacement or alternative treatment. Return the product to your pharmacy.
Recall at a glance
- Quantity recalled
- 91 vials
Why it was recalled
Northwest Compounders (Beaverton, OR) is recalling Semaglutide-Glycine-Cyanocobalamin Injectable in 0.5 mL vials (2.5 mg, 5 mg, and 1 mg/mL strengths) due to lack of assurance of sterility. The affected product is a prescription injectable medication distributed by Payless Compounders, LLC.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Semaglutide-Glycine-Cyanocobalamin Injectable
- Strength
- 2.5 mg
Where it was sold
Distributed in Oregon.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Editorial summary by Recall Canary · summary updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification